Ambys Medicines Completes $47 Million Series A Extension
SOUTH SAN FRANCISCO -- Ambys Medicines, a company pioneering cell-based therapies for severe liver diseases,…
SOUTH SAN FRANCISCO -- Ambys Medicines, a company pioneering cell-based therapies for severe liver diseases,…